2don MSN
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing ...
FDA Commissioner Dr. Marty Makary joins 'Squawk Box' to discuss plans to speed up the approval of biosimilar generic drugs in ...
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
The U.S. Food and Drug Administration announced plans to reduce the amount of fluoride present in ingestible children’s products.
Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary ...
It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
On Wednesday, Oct. 29, the Food and Drug Administration (FDA) issued draft guidance proposing to update its biosimilar review framework. Under the ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
The FDA is undergoing a major transformation in its drug approval processes, regulatory oversight and transparency ...
The FDA has revealed a set of measures designed to increase the availability of biosimilars in the U.S. and in turn reduce ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback